Current evidence for a genetic modulation of the response to analgesics

This publication has 24 references indexed in Scilit:

• COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
  NeuroImage, 2005
• Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
  New England Journal of Medicine, 2004
• The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
  Acta Anaesthesiologica Scandinavica, 2004
• Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor
  Journal of Neurochemistry, 2004
• Genetic Predictors of the Clinical Response to Opioid Analgesics
  Clinical Pharmacokinetics, 2004
• The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
  Pharmacogenetics, 2002
• Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
  Proceedings of the National Academy of Sciences, 2000
• Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
  Proceedings of the National Academy of Sciences, 1998
• Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation
  Published by Wolters Kluwer Health ,1998
• Quick Onset of Severe Abdominal Pain After Codeine in an Ultrarapid Metabolizer of Debrisoquine
  Therapeutic Drug Monitoring, 1997